Edition:
United Kingdom

Varian Medical Systems Inc (VAR.N)

VAR.N on New York Stock Exchange

135.92USD
7:18pm BST
Change (% chg)

$0.00 (+0.00%)
Prev Close
$135.92
Open
$136.69
Day's High
$137.54
Day's Low
$135.08
Volume
29,763
Avg. Vol
151,170
52-wk High
$142.50
52-wk Low
$101.44

Summary

Name Age Since Current Position

R. Andrew Eckert

57 2014 Independent Chairman of the Board

Dow Wilson

59 2012 President, Chief Executive Officer, Director

Timothy Guertin

69 2012 Independent Vice Chairman of the board

Gary Bischoping

50 2017 Chief Financial Officer, Senior Vice President - Finance

Chris Toth

39 2018 President - Varian Oncology Systems

Kolleen Kennedy

59 2018 Executive Vice President, President - Proton Solutions Division and Chief Growth Officer

John Kuo

55 2012 Senior Vice President, General Counsel, Corporate Secretary

Anat Ashkenazi

46 2018 Independent Director

Jeffrey Balser

56 2018 Independent Director

Judy Bruner

60 2016 Independent Director

Jean-Luc Butel

62 2017 Independent Director

Regina Dugan

55 2013 Independent Director

David Illingworth

65 2011 Independent Director

Mike Bruff

2018 Vice president, IR Contact Officer

Biographies

Name Description

R. Andrew Eckert

Mr. R. Andrew Eckert serves as Independent Chairman of the Board of the Company. He served as Chief Executive Officer, Valence Health, a healthcare solutions Company, Chief Executive Officer, TriZetto Corporation, a healthcare IT solutions firm (March 2014—November 2014).Chief Executive Officer, CRC Health Corporation, a provider of substance abuse treatment and adolescent youth services (January 2011—March 2014).He is Managing Director, Symphony Technology Group, a private equity firm (October 2009—January 2011),President and Chief Executive Officer, Eclipsys Corporation, a former publicly traded healthcare information management software provider (October 2005—May 2009),Chief Executive Officer, SumTotal Systems, Inc., an enterprise software provider. He is Chief Executive Officer, Docent Inc., an enterprise software provider that was acquired by SumTotal Systems (2002—2004),Other Current Public Company Board Memberships: Becton, Dickinson and Company, a global medical technology company.

Dow Wilson

Mr. Dow R. Wilson serves as President, Chief Executive Officer, Director of the Company. Mr. Wilson served as Corporate Executive Vice President and Chief Operating Officer from October 2011 through September 2012 and as Corporate Executive Vice President and President, Oncology Systems from August 2005 through September 2011. Mr. Wilson served as Corporate Vice President and President, Oncology Systems from January 2005 to August 2005. Prior to joining the Company in January 2005, Mr. Wilson was Chief Executive Officer of the Healthcare-Information Technologies business in General Electric (a diversified technology and services company), from 2003 to 2005. During the previous 18 years, Mr. Wilson held various management positions within General Electric. Mr. Wilson holds a B.A. degree in English from Brigham Young University and an M.B.A. degree from Dartmouth’s Amos Tuck School of Business. Mr. Wilson serves on the board of directors of Varex Imaging Corporation, our former Imaging Components business segment. He also served on the board of directors of Saba Software, Inc. (an e-learning software provider) from August 2006 to March 2015 and as the lead independent director of that board from August 2011 to March 2013.

Timothy Guertin

Mr. Timothy E. Guertin serves as Independent Vice Chairman of the board of the Company. He served as president and chief executive officer of the company from 2006 to 2012. Mr. Guertin joined Varian in 1976 and since then has served in major management positions over his 30-plus years with the company. Prior to being appointed CEO in February, 2006, he served as Varian's president and chief operating officer. Mr. Guertin was named a corporate vice president in 1992 and executive vice president in 1999. At one time he was general manager and then president of Varian's Oncology Systems business, the company's largest business and the world's leading supplier of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, and brachytherapy. Prior to becoming head of the Oncology Systems business, he held a variety of positions, including general manager of customer support. He holds a BS in electrical engineering and computer sciences from the University of California at Berkeley. Mr. Guertin is the current chairman of the Board of Directors of the AeA (American Electronics Association), a nationwide trade association that represents all segments of the technology industry, and he is a member of that organization's Silicon Valley/Northern California Council. He is also a member of the Board of Directors of the Diagnostic Imaging Section of NEMA (National Electrical Manufacturers Association), and he serves as chairman of NEMA's Therapy Systems Division. In addition, he sits on the corporate councils of the American Society of Therapeutic Radiology and Oncology (ASTRO), and the Canadian Association of Radiation Oncologists (CARO), professional organizations of radiation oncology clinicians.

Gary Bischoping

Mr. Gary E. Bischoping, Jr., serves as Chief Financial Officer, Senior Vice President - Finance of the Company. Prior to joining the Company, Mr. Bischoping was with Dell Technologies for 17 years where he held several management roles, including CFO of its Client Solutions Group. Before joining Dell, Mr. Bischoping worked in financial management consulting for Stern Stewart & Company, Xerox and the SK Group. Mr. Bischoping earned his M.B.A. degree from the Simon School of Business at the University of Rochester and a B.S. degree in Accounting from the State University of New York at Oswego. He passed the Certified Public Accountants examination in 1991.

Chris Toth

Mr. Chris Toth is President - Varian Oncology Systems of the Company. Christopher A. Toth was appointed President of Oncology Systems effective October 2018. Mr. Toth joined Varian in 2001 and has held multiple cross-functional roles and executive positions during his tenure with the company. Prior to his appointment as President of Oncology Systems, Mr. Toth served as President of Global Commercial and Field Operations from January 2017 to September 2018, where he was responsible for global sales strategy and execution for Oncology Systems and Proton Solutions. Additionally, in this role, Mr. Toth was responsible for global field service, applications training, market access and regional marketing for the Oncology Systems business. From September 2014 to January 2017, Mr. Toth was President, Oncology Systems Americas and from April 2011 to September 2014, Vice President, Global Marketing. Mr. Toth holds a B.A. degree in Business Administration with a concentration in Marketing from the Lundquist College of Business at the University of Oregon.

Kolleen Kennedy

Ms. Kolleen T. Kennedy serves as Executive Vice President, President - Proton Solutions Division and Chief Growth Officer of the Company. From January 2006 through September 2011, Ms. Kennedy served as Vice President, Oncology Systems Customer Service and Support. Prior to that, Ms. Kennedy was the Company’s Vice President, Oncology Systems Marketing, Product Management and Engineering from September 2004 to January 2006. Prior to becoming Vice President, Ms. Kennedy served in various marketing management positions since she joined the Company in 1997. Ms. Kennedy holds a B.S. degree in Radiation Oncology and a B.S. degree in Psychology, both from Wayne State University, as well as an M.S. in Medical Physics from the University of Colorado.

John Kuo

Mr. John W. Kuo serves as Senior Vice President, General Counsel, Corporate Secretary of the Company. Prior to that, he served as Corporate Vice President and General Counsel from July 2005 through January 2012 and as Corporate Secretary since February 2005. Mr. Kuo joined the Company as Senior Corporate Counsel in March 2003 and became Associate General Counsel in March 2004. Prior to joining the Company, Mr. Kuo was General Counsel and Secretary at BroadVision, Inc. (an e-commerce software provider) and held senior legal positions at 3Com Corporation (a networking equipment provider). Mr. Kuo has previously been with the law firms of Gray Cary Ware & Freidenrich (now DLA Piper) and Fulbright & Jaworski. Mr. Kuo holds a B.A. degree from Cornell University and a J.D. degree from Boalt Hall School of Law at the University of California at Berkeley.

Anat Ashkenazi

Ms. Anat Ashkenazi serves as Independent Director of the Company., effective December 01, 2018. She had been Senior Vice President, Controller and Chief Financial Officer of Lilly Research Labs and Vice President, Finance and Chief Financial Officer, Lilly Diabetes and Lilly Global Manufacturing and Quality (April 2015—September 2016) ,Chief Financial Officer, Lilly Oncology (October 2013—April 20.

Jeffrey Balser

Dr. Jeffrey R. Balser, M.D., Ph.D. is Independent Director of the Company. He has served as the president and CEO of Vanderbilt University Medical Center since 2016 and the dean of Vanderbilt University School of Medicine since 2008. During this time, he has led the Medical Center through a period of increased service volume with major inpatient expansions of the children's hospital and the adult critical care areas. Dr. Balser earned his medical and PhD degrees from Vanderbilt University and completed his residency and fellowship training at The Johns Hopkins Hospital. Additionally, he earned a Bachelor of Science degree in Engineering from Tulane University.

Judy Bruner

Ms. Judy Bruner serves as Independent Director of the Company. She Served Positions at SanDisk Corporation, a global leader in flash memory storage solutions, Executive Vice President, Administration and Chief Financial Officer and Member of Board of Directors (June 2002—July 2004).Senior Vice President and Chief Financial Officer, Palm, Inc., a manufacturer of personal digital assistants , She is Vice President, Finance & Corporate Controller, 3Com Corporation, a digital electronics manufacturer Other Current Public Company Board Memberships: Brocade Communications Systems, Inc., a technology company specializing in data and storage networking products; Applied Materials, Inc., a provider of engineering solutions; Rapid7, a security data and analytics solutions provider.

Jean-Luc Butel

Mr. Jean-Luc Butel serves as Independent Director of the Company. Mr. Butel, has served as Senior Adviser to McKinsey Healthcare Practice since 2015. From 2012 to 2015, Butel served as Corporate Vice President and President of International atBaxter. He has held prior executive management positions at Medtronic, Johnson & Johnson, and Becton-Dickinson. Butel earned a BA in International Affairs from TheGeorge Washington Universityand a MBA in international management from the American Graduate School of International Management (Thunderbird). Butel is a member of the Board of Directors of the Singapore Economic Development Board and Takeda Pharmaceutical Company.

Regina Dugan

Dr. Regina E. Dugan serves as Independent Director of the Company. She served as Vice President of Engineering, Facebook, Inc., Vice President of Engineering at Google, Inc., a global technology company, leading the Advanced Technology and Products group (a group charged with breakthrough innovations in mobile computing and accelerating the development of promising technologies to market. She is Senior Vice President, Google Inc. and Motorola Mobility LLC, a mobile technology company Google acquired in May 2012, Director, Defense Advanced Research Projects Agency (DARPA), a research and development organization of the U.S. Department of Defense (July 2009—March 2012), Co-Founder, President and Chief Executive Officer, RedXDefense LLC, a security solutions company. She is Co-Founder, President and Chief Executive Officer, Dugan Ventures, an investment firm ,Other Current Public Company Board Memberships: Zynga Inc., a social game developer.

David Illingworth

Mr. David J. Illingworth Dave serves as Independent Director of the Company. He served as Chief Executive Officer, Smith & Nephew plc, a medical devices company, Chief Operating Officer and Division President, Smith & Nephew plc. He served Other Senior Management Experience: President, XL Vision, Inc.; Chairman and Chief Executive Officer, VidaMed, Inc.; President, Nellcor Puritan Bennett LLC; and Managing Director, Asia/Pacific, GE Medical Systems. Other Current Public Company Board Memberships: Domtar, Inc., a manufacturer of fiber-based products. Public Company Board Memberships in Past Five Years: Smith & Nephew plc.

Mike Bruff

Basic Compensation

Name Fiscal Year Total

R. Andrew Eckert

444,750

Dow Wilson

10,276,400

Timothy Guertin

270,500

Gary Bischoping

2,873,880

Chris Toth

--

Kolleen Kennedy

3,933,970

John Kuo

2,509,300

Anat Ashkenazi

--

Jeffrey Balser

--

Judy Bruner

307,500

Jean-Luc Butel

286,250

Regina Dugan

276,500

David Illingworth

285,250

Mike Bruff

--
As Of  28 Sep 2018

Options Compensation